GAM Holding’s Sarepta Therapeutics SRPT Stock Holding History

GAM Holding’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,186	Closed	-$539K	–	263
2022 Q2	$539K	Hold	7,186	–	–	0.04%	207
2022 Q1	$561K	Hold	7,186	–	–	0.03%	222
2021 Q4	$647K	Hold	7,186	–	–	0.03%	225
2021 Q3	$665K	Hold	7,186	–	–	0.03%	218
2021 Q2	$559K	Sell	7,186 -1	-0%	-$76	0.02%	249
2021 Q1	$536K	Buy	+7,187	New	+$663K	0.02%	259
2020 Q4	–	Sell	-32,931	Closed	-$4.62M	–	328
2020 Q3	$4.62M	Buy	32,931 +5	+0%	+$760	0.28%	110
2020 Q2	$5.28M	Sell	32,926 -6,206	-16%	-$845K	0.33%	93
2020 Q1	$3.83M	Buy	39,132 +3	+0%	+$343	0.26%	112
2019 Q4	$5.05M	Buy	39,129 +3	+0%	+$303	0.24%	127
2019 Q3	$2.95M	Hold	39,126	–	–	0.13%	179
2019 Q2	$5.95M	Hold	39,126	–	–	0.23%	111
2019 Q1	$4.66M	Buy	39,126 +24,626	+170%	+$3.17M	0.2%	127
2018 Q4	$1.58M	Buy	+14,500	New	+$1.81M	0.08%	265
2018 Q2	–	Sell	-23,200	Closed	-$1.72M	–	961
2018 Q1	$1.72M	Hold	23,200	–	–	0.06%	319
2017 Q4	$1.29M	Buy	+23,200	New	+$1.23M	0.04%	503

Other funds holding SRPT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GAM Holding's SRPT Position: Q3 2022 in Review

GAM Holding sold out of Sarepta Therapeutics (SRPT) in Q3 2022, closing a stake of 7,186 shares — an estimated $539K sold.

GAM Holding first reported a position in SRPT in Q4 2017 and held it in 16 quarters. The position peaked at $5.95M in Q2 2019. 375 funds tracked by Wall St. Rank hold SRPT as of Q3 2022.

GAM Holding reported no remaining Sarepta Therapeutics position as of Q3 2022 after selling out during the quarter.
GAM Holding sold 7,186 Sarepta Therapeutics shares in Q3 2022, an estimated $539K.
GAM Holding first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 16 quarters.
GAM Holding's Sarepta Therapeutics position peaked at $5.95M in Q2 2019.
375 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2022.

Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.